Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
lswicker@well.ox.ac.uk

Linda Wicker

Recent publications

The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
Journal article

Marcovecchio ML. et al, (2024), Diabetologia
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells
Journal article

Inaba A. et al, (2023), Nature Communications, 14
SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile
Journal article

Zhang J-Y. et al, (2023), Genome Medicine, 15
Gene expression signature predicts rate of type 1 diabetes progression.
Journal article

Suomi T. et al, (2023), EBioMedicine, 92
Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes
Journal article

Zhang J-Y. et al, (2022), Nature Communications, 13

More publications